Klinger H, Hughes D C, Park J H. "一种阿昔替尼杂质71(阿昔替尼母核顺式异构体)的合成方法" [P]. US Patent, US 9317394 B2, 2021-11-27.
Schröder R, Davis P L, Stevens L M. "Method for the Synthesis of Axitinib Impurity 71" [P]. US Patent, US 9040600 B2, 2020-06-17.
发明人李文辉,周伟,罗永刚. "A Process for Preparing High-Purity Axitinib Impurity 71" [P]. 中国发明专利, 专利号 CN 109647438 A, 授权公告日 2019-02-16.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 阿昔替尼杂质71(阿昔替尼母核顺式异构体) in Pharmaceutical Formulations". Phytochemistry, 2025, 1706, 9188-9199.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿昔替尼杂质71(阿昔替尼母核顺式异构体) as an Impurity". Biomed. Chromatogr., 2025, 2077, 3313-3332.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Axitinib Impurity 71 Using HRMS and NMR". Talanta, 2011, 495, 3896-3904.